跳至主要内容
临床试验/NCT02455921
NCT02455921已完成4 期

Comparative Effect of Neuromuscular Blockade Reversal Agent on Extubation Conditions, Postoperative Cognitive Function and Behaviour of School-aged Children Undergoing Ear Note Throat (ENT) Surgery

Attikon Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
time of achieving extubation

研究概览

简要总结

The aim of this prospective randomized study is to investigate comparatively the effect of neostigmine-atropine versus sugammadex on speed and quality of recovery and on postoperative cognitive function & behavior in children undergoing ENT surgery under general anaesthesia.

详细描述

The aim of this prospective randomized study is to investigate comparatively the effect of neostigmine-atropine vs sugammadex on time of achieving extubation, quality of recovery, postoperative cognitive function and behaviour of children undergoing ENT surgery under general anaesthesia.

In this study after parental approval has been obtained, children with age 6-12 yrs undergoing tonsillectomy and/or adenoidectomy under general anaesthesia will be included. General anaesthesia will be performed using Total Intravenous Anaesthesia (TIVA) technique with continuous infusion of propofol and remifentanil. Rocuronium will be used to achieve neuromuscular blockade (NMB). Neuromuscular reversal will be performed using either atropine-neostigmine or sugammadex. Patients will be divided into 2 groups according to the type of NMB reversal agent used. Intraoperative monitoring will include Bispectral Index Sedation (BIS), SpO2, capnography, noninvasive measurements of blood pressure, heart rate and train of four (TOF).

Children will be assessed preoperatively (one day before surgery and at the morning of day of surgery), intraoperatively, immediate postoperatively and will be followed up for 15 postoperative days. Additionally, parents will be cooperated and questioned.

The primary end-points of the study include the comparative investigation of the effect of neostigmine-atropine vs sugammadex on time of achieving extubation, quality of recovery, and postoperative cognitive function of children. Secondary endpoints will include side effects, signs of residual neuromuscular blockade, agitation and postoperative behavioural changes of children.

For this purpose the following scales and questionnaires will be used:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Single (Investigator)

入排标准

年龄范围
6 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children undergoing ENT surgery under general anaesthesia.

排除标准

  • Parents refusal
  • Cognitive impairment
  • Difficulty in communication due to language issues
  • Psychiatric disorder
  • Severe systematic disorder
  • Known allergy to any drug used

研究组 & 干预措施

sugammadex

Active Comparator

iv sugammadex 2 mg/Kg

干预措施: Sugammadex (Drug)

neostigmine - atropine

Active Comparator

iv neostigmine 0,05 mg/Kg - atropine 0,02 mg/kg

Efficacy, safety and effect on cognitive and behavioural function

干预措施: neostigmine - atropine (Drug)

结局指标

主要结局

time of achieving extubation

时间窗: 10 min

time of achieving extubation

次要结局

  • Behavioural function(up to 15th postoperative day)
  • signs of residual neuromuscular blockade(1 hour)

研究者

发起方
Attikon Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Paraskevi Matsota

Associate Professor of Anaesthesiology

Attikon Hospital

研究点 (1)

Loading locations...

相似试验